| 摘要 |
A method is disclosed for prevention and/or treatment of diseases in which 5- and 12-lipoxygenase activity contributes to the pathological condition, by administration of 12-methyltetradecanoic acids alone and in conjunction with other therapeutic compounds. Methods to inhibit lipoxygenase mediated cancers and inflammations are disclosed. |
